Last reviewed · How we verify
NCT04093479
Impact of Maternal BMI on Plasma Levels of Oxytocin During Labor Augmentation
trial testing blood samples in Maternal Obesity During Childbirth in 40 participants. Completed in 1 August 2020.
1 December 2019
Quick facts
| Lead sponsor | Linkoeping University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 October 2019 |
| Primary completion | 1 December 2019 |
| Estimated completion | 1 August 2020 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- blood samples — full drug profile →
Conditions studied
- Maternal Obesity During Childbirth — all drugs for Maternal Obesity During Childbirth →
- Labor; Arrested Active Phase — all drugs for Labor; Arrested Active Phase →
Sponsor
Linkoeping University
Who can join
18 and older, female only, with Maternal Obesity During Childbirth or Labor; Arrested Active Phase. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to examine the associations between maternal BMI and levels of oxytocin in maternal plasma during augmentation with oxytocin during first stage of labor in term pregnancy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The association between maternal body mass index and serial plasma oxytocin levels during labor.
Ramö Isgren A, Carlhäll S, Dennis Retrato M, Kodikara C, et al · · 2023 · cited 1× · PMID 37566578 · DOI 10.1371/journal.pone.0290038
Verify or expand the search:
- PubMed search for NCT04093479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of blood samples
Trials testing the same drug.
- NCT07070102 — Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children · not yet recruiting
- NCT06252415 — Evaluation of Rapid First-line Genome Sequencing for Prenatal Diagnosis of Congenital Malformations in Comparison With C · completed
- NCT05472883 — Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES) · NA · recruiting
- NCT05472519 — Immunopathology of Loeys-Dietz Syndrome · NA · completed
- NCT07069296 — Impact of Gestational Diabetes on Childhood Obesity · NA · completed
Other Linkoeping University trials
Trials by the same sponsor.
- NCT07494422 — A Path to Prevention of Elder Abuse in Long-term Care. Prevalence Study Among Staff in Long-term Care. · not yet recruiting
- NCT07485439 — Self-inspired & Tailored Autism Movement With Phystic App · NA · enrolling by invitation
- NCT07391540 — ICBT for Psychological Symptoms Related to Economy · NA · recruiting
- NCT07181213 — Genetic Predisposition to High Blood Pressure · NA · enrolling by invitation
- NCT07312136 — MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04093479 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Linkoeping University
- Last refreshed: 21 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04093479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing